PCN152 Patient-Relevant Endpoints (PRE) in Oncology - Current Issues in the Context of Early Benefit Assessment (EBA) in Germany- An Industry Perspective
Abstract
Authors
I. Dabisch J. Dethling C.M. Dintsios M. Drechsler D. Kalanovic P. Kaskel F. Langer J. Ruof T. Ruppert D. Wirth